Suppr超能文献

穿透性角膜移植术后免疫性移植排斥反应导致的视力康复与眼压升高

[Visual rehabilitation and intraocular pressure elevation due to immunological graft rejection following penetrating keratoplasty].

作者信息

Nguyen N X, Langenbucher A, Cursiefen C, Seitz B, Wenkel H, Küchle M

机构信息

Augenklinik mit Poliklinik der Universität Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen.

出版信息

Klin Monbl Augenheilkd. 2001 Jul;218(7):492-7. doi: 10.1055/s-2001-16292.

Abstract

PURPOSE

Endothelial graft rejection and intraocular pressure elevation are the most common causes of graft failure following penetrating keratoplasty (PK). Aim of this study was to evaluate the visual rehabilitation and the development of intraocular pressure during and after graft rejection.

PATIENTS AND METHODS

The study included 20 eyes of 20 patients (age 54.7 +/- 19.8 years) with endothelial graft rejection, that fulfilled the following inclusion criteria 1) graft rejection was diagnosed and treated in our department; 2) at least one year follow-up after graft rejection; 3) avascular corneal pathology. The mean follow-up was 23 +/- 14 months. According to the type of surgical procedure patients were classified in PK only (n = 15, one after cataract extraction), PK combined with extracapsular cataract extraction and intraocular lens (IOL) implantation (n = 1); PK combined with secondary IOL-implantation or IOL-exchange (n = 4). Standardized complete ophthalmological examinations were performed on a regular basis before, during the acute graft rejection und then regularly in a defined examination raster in an out-patient service with cornea specialization.

RESULTS

The time interval between first symptom of 18 acute diffuse and 2 chronic focal graft rejection and start of treatment was 9 +/- 13 days. Best-corrected visual acuity (CVA) was 0.6 +/- 0.2 before graft rejection and decreased significantly at the time of diagnosis (0.2 +/- 0.2; p = 0.001). Six weeks after graft rejection CVA was 0.5 +/- 0.2 and remained almost stable until one year after rejection (0.6 +/- 0.3) in 16 patients with reversible graft rejection. Only 4 patients (20%) showed an irreversible graft failure requiring Re-PK. Intraocular pressure (IOP) was not elevated in 75% of the patients (n = 15) and did not need any antiglaucomatous treatment during and after the rejection phase. In 5 eyes (25%) (3 after PK combined with anterior chamber IOL-explantation and secondary posterior chamber IOL-implantation; 1 with secondary pseudoexfoliation glaucoma and 1 steroidal responder) IOP was elevated during graft rejection (26 +/- 7 mmHg), but was controlled by intensive topical antiglaucomatous treatment.

CONCLUSION

Typically, the visual rehabilitation after graft rejection was good if the clinical signs were diagnosed just in time and treated adequately. There is no direct correlation between graft rejection and intraocular pressure elevation. However, the development of intraocular pressure elevation seems to be strongly associated with preexisting glaucoma, preexisting anterior synechiae and/or simultaneous anterior chamber lens implant removal. A careful patient management after PK plays an important role to prevent the development of irreversible graft failure due to graft rejection.

摘要

目的

内皮移植排斥反应和眼压升高是穿透性角膜移植术(PK)后移植失败的最常见原因。本研究的目的是评估移植排斥反应期间及之后的视力恢复情况和眼压变化。

患者与方法

本研究纳入了20例患者的20只眼(年龄54.7±19.8岁),这些患者患有内皮移植排斥反应,符合以下纳入标准:1)移植排斥反应在我们科室被诊断并接受治疗;2)移植排斥反应后至少随访一年;3)角膜无血管病变。平均随访时间为23±14个月。根据手术方式,患者分为仅接受PK手术组(n = 15,其中1例在白内障摘除术后)、PK联合白内障囊外摘除及人工晶状体(IOL)植入组(n = 1)、PK联合二期IOL植入或IOL置换组(n = 4)。在急性移植排斥反应前、期间定期进行标准化的全面眼科检查,然后在角膜专科门诊按照确定的检查模式定期进行检查。

结果

18例急性弥漫性和2例慢性局限性移植排斥反应的首发症状至开始治疗的时间间隔为9±13天。移植排斥反应前最佳矫正视力(CVA)为0.6±0.2,诊断时显著下降(0.2±0.2;p = 0.001)。移植排斥反应六周后,16例可逆性移植排斥反应患者的CVA为0.5±0.2,直至排斥反应后一年(0.6±0.3)几乎保持稳定。只有4例患者(20%)出现不可逆的移植失败,需要再次进行PK手术。75%的患者(n = 15)眼压未升高,在排斥反应期间及之后不需要任何抗青光眼治疗。5只眼(25%)(3例在PK联合前房IOL取出及二期后房IOL植入术后;1例患有继发性假性剥脱性青光眼,1例为类固醇反应者)在移植排斥反应期间眼压升高(26±7 mmHg),但通过强化局部抗青光眼治疗得到控制。

结论

通常,如果临床症状及时诊断并得到充分治疗,移植排斥反应后的视力恢复良好。移植排斥反应与眼压升高之间无直接关联。然而,眼压升高的发生似乎与既往青光眼、既往虹膜粘连和/或同时进行的前房晶状体植入物取出密切相关。PK术后仔细的患者管理对于预防因移植排斥反应导致的不可逆移植失败起着重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验